SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11313302
Source:
http://linkedlifedata.com/resource/pubmed/id/11313302
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003241
,
umls-concept:C0008976
,
umls-concept:C0010346
,
umls-concept:C0034656
,
umls-concept:C0086418
,
umls-concept:C0205177
,
umls-concept:C0812246
,
umls-concept:C1456820
pubmed:issue
6
pubmed:dateCreated
2001-4-23
pubmed:abstractText
We evaluated CDP571, a humanized antibody to tumor necrosis factor, for the treatment of active Crohn's disease.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374630
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/CDP 571
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0016-5085
pubmed:author
pubmed-author:ArchambaultAA
,
pubmed-author:BakerJ PJP
,
pubmed-author:BernsteinC NCN
,
pubmed-author:CDP571 Crohn's Disease Study Group
,
pubmed-author:FeaganB GBG
,
pubmed-author:HanauerS BSB
,
pubmed-author:HawkeyCC
,
pubmed-author:HeathP KPK
,
pubmed-author:KammM AMA
,
pubmed-author:NovakCC
,
pubmed-author:PresentD HDH
,
pubmed-author:SandbornW JWJ
,
pubmed-author:SutherlandL RLR
,
pubmed-author:TarganS RSR
,
pubmed-author:WoldD ADA
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1330-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11313302-Adolescent
,
pubmed-meshheading:11313302-Adult
,
pubmed-meshheading:11313302-Aged
,
pubmed-meshheading:11313302-Antibodies, Monoclonal
,
pubmed-meshheading:11313302-Crohn Disease
,
pubmed-meshheading:11313302-Dose-Response Relationship, Drug
,
pubmed-meshheading:11313302-Double-Blind Method
,
pubmed-meshheading:11313302-Female
,
pubmed-meshheading:11313302-Humans
,
pubmed-meshheading:11313302-Male
,
pubmed-meshheading:11313302-Middle Aged
,
pubmed-meshheading:11313302-Tumor Necrosis Factor-alpha
pubmed:year
2001
pubmed:articleTitle
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
pubmed:affiliation
Mayo Clinic, Rochester, Minnesota 55905, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't